App-based workers move SC seeking social security benefit from Uber, Ola, Swiggy, Zomato indiatoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatoday.in Daily Mail and Mail on Sunday newspapers.
Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe cases of Covid-19.Biophore has .
Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe cases of Covid-19.
India News: HYDERABAD: Hyderabad-based Biophore India Pharmaceuticals on Friday said it has sought emergency use approval from the Drugs Controller General of Ind.
Updated:
March 01, 2021 21:56 IST
Third phase of vaccination against COVID-19 gets off to a start; technical glitch in CoWIN2.0 portal delayed registration of names
Share Article
AAA
Third phase of vaccination against COVID-19 gets off to a start; technical glitch in CoWIN2.0 portal delayed registration of names
The third phase of the vaccination campaign against COVID-19 got off to a start here on Monday with the district administration aiming to administer the Covishield vaccine to nearly four-and-a-half lakh senior citizens.
In the first and second phases, healthcare workers and frontline workers had been vaccinated respectively. Nearly 90 per cent of healthcare workers and about 50 per cent of the frontline workers had been covered since the roll-out.